You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海醫藥(601607.SH):擬7.5億元受讓上藥生物醫藥100%股權
格隆匯 05-27 18:38

格隆匯5月27日丨上海醫藥(601607.SH)公佈,公司於2021年5月27日召開第七屆董事會第二十三次會議,審議通過了《關於擬受讓控股股東全資子公司100%股權暨關聯/連交易的議案》;同日,與控股股東上藥集團全資子公司上海新先鋒藥業有限公司(簡稱“上海新先鋒”)在上海簽署了《股權轉讓協議》:上海醫藥擬以約人民幣7.5億元(以最終國資備案價格為準)受讓上海上藥生物醫藥有限公司(簡稱“上藥生物醫藥”)100%的股權。

上藥生物醫藥的核心資產是位於張江路92號的一塊產業用地的使用權。張江路92號位處生物醫藥產業聚集的張江高科技園區腹地,地理位置優越,周邊聚集大批電子、信息、生物技術等方面的高科技企業,擁有完備的公共工程配套設施,極其適合生物醫藥基地的建設。目前,張江路92號在市場上屬於稀缺性土地資源,張江高新技術園區核心區域內已經沒有規模完整、面積相近的產業用地。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account